CIK 0001574235
- Non-accelerated filer
- Smaller reporting company
Pulmatrix, Inc.
Sign in to watch- Ticker
- PULM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 461821392
- Phone
- +1 888-355-4440
- Business address
- 945 CONCORD STREET, SUITE 1217, FRAMINGHAM, MA, 01701
- Former names
- Ruthigen, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-26 | Raad Teofilo David Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +34,900 | 34,900 | ||
| 2022-01-27 | Raad Teofilo David Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +750,000 | 750,000 | ||
| 2021-01-28 | Raad Teofilo David Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +565,500 | 565,500 | ||
| 2020-04-02 | Raad Teofilo David Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2020-01-09 | Raad Teofilo David Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +781,800 | 781,800 | ||
| 2020-01-09 | Raad Teofilo David Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +471,460 | 471,460 | ||
| 2019-05-16 | Raad Teofilo David Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +320,000 | 320,000 | ||
| 2018-06-05 | Raad Teofilo David Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +741,000 | 741,000 | ||
| 2017-05-01 | Raad Teofilo David Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +330,500 | 330,500 |
Page 1 of 1 · 9 trades